GADD45B and melanoma: Furthermore, GADD45B has demonstrated potential in overcoming drug resistance, a common challenge in melanoma treatment, by sensitizing tumor cells to chemotherapy [21], This dual role—both in immion and in combating drug resistance—positions GADD45B as a promising therapeutic target in SKCM.” Therefore, GADD45B might be essential for the survival of cancer cells.